查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1861835

攜帶式診斷影像設備市場按產品類型、便攜性類型、應用、最終用戶、技術和價格分佈－2025-2032年全球預測

Portable Diagnostic Imaging Market by Product Type, Portability Type, Application, End User, Technology, Price Range - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，可攜式診斷成像市場規模將達到 476.9 億美元，複合年成長率為 8.08%。

關鍵市場統計數據
基準年 2024 255.9億美元
預計年份：2025年 277.1億美元
預測年份 2032 476.9億美元
複合年成長率 (%) 8.08%

權威地介紹了由小型化、互聯互通和臨床工作流程變革驅動的診斷影像快速去中心化進程。

攜帶式診斷影像設備已從醫院影像實驗室的專用設備發展成為種類繁多的設備，使患者能夠更便捷地獲得診斷服務。這項轉變得益於技術小型化、數位訊號處理技術的進步以及無線連接技術的日趨成熟，這些技術使得設備能夠在臨床、現場和家庭環境中可靠運作。因此，醫療服務路徑正變得更加分散化，診斷服務不再集中於中心化，而是在需要的地方提供。

影像技術與雲端運算和邊緣分析的整合正在重塑臨床工作流程，並加速分流決策。臨床醫生正在利用攜帶式CT、各種MRI設備、超音波、分子影像和小型X光系統來收集可操作的資訊，而這些資訊以前需要患者轉運或延誤就診時間。從急救響應到家庭慢性病監測，這些技術正在擴大診斷服務的覆蓋範圍，並支持更及時的干涉措施。同時，設計重點正在轉向符合人體工學的外形、更高的能源效率和更簡化的使用者介面，從而最大限度地減少培訓負擔，並簡化與非傳統醫療環境的整合。

在產品開發週期中，監管和互通性標準的重要性日益凸顯，相關人員對資料安全和臨床療效的期望也是如此。因此，產品的普及不僅取決於其效能，還取決於供應商能否提供強力的臨床證據、可靠的生命週期支援和安全的資料管理。本文透過分析產業現狀、影響近期競爭優勢的因素以及決定哪些攜帶式診斷成像解決方案能夠獲得廣泛且持續應用的關鍵營運考量，為後續分析建立了框架。

小型化、軟體主導的生態系統、模組化互通性和供應鏈韌性如何共同重塑攜帶式診斷成像格局

攜帶式診斷影像領域正經歷一場深刻的技術主導變革，這場變革正在改變臨床實務、採購模式和病患診療路徑。感測器小型化和低場磁振造影架構的技術進步，使得設備更加輕巧、節能，也更容易在受限環境中部署。同時，超音波系統也正從大型主機發展成為具備極其先進影像處理能力的攜帶式和智慧型手機連接設備。人工智慧輔助影像分析和自動化測量工具的引入，降低了專業技能的門檻，並將潛在用戶群擴展到診斷成像專家之外。

連結性和軟體定義功能也正在創造新的價值層面。雲端對應平臺和邊緣運算支援安全影像傳輸、遠端會診和持續軟體改進，無需更換硬體，從而延長設備使用壽命並實現基於訂閱的軟體盈利模式。同時，模組化和平台化方法促進了不同模式之間的互通性，使醫療機構更容易將攜帶式設備整合到現有的臨床資訊系統中。因此，採購決策越來越受到設備生態系統相容性和長期軟體藍圖的影響，而不僅僅是硬體特性。

隨著急診、門診中心和居家醫療機構採用照護現場技術加快診斷速度，臨床工作流程模式正在轉變。部分地區的健保報銷政策調整以及旨在縮短患者周轉時間的營運獎勵，都為這一轉變提供了支持。此外，近期全球範圍內的動盪使得供應鏈韌性和零件採購的地域多元化成為策略重點，迫使許多製造商重新評估其籌資策略，並增加關鍵零件的在地採購。這些變革性變化正在重新定義攜帶式診斷影像設備的競爭優勢，並影響產品藍圖、商業模式和監管應對措施。

評估美國關稅政策在2025年前對診斷影像產業供應鏈策略、採購權衡和商業性差異化的影響

美國關稅的實施和調整（直至2025年）對攜帶式診斷成像設備供應鏈中的製造商、經銷商和醫療採購商產生了切實的影響。影響關鍵零件、原料和成品的關稅衝擊了成本結構，促使企業重新評估籌資策略，並評估區域製造地和售後支援地點的財務可行性。許多企業正在採取措施降低懲罰性關稅和運輸延誤的風險，例如供應商多元化、增加庫存緩衝或加快組裝和測試流程的本地化。

這些變化不僅限於成本。關稅也會與監管合規和物流複雜性相互作用，影響產品上市時間和定價透明度。依賴跨境採購的供應商可能面臨更長的前置作業時間和更複雜的保固管理。因此，採購團隊和臨床負責人必須仔細權衡短期採購成本節約與長期可維護性、備件供應以及全生命週期總擁有成本之間的利弊。與此同時，各公司正在重新思考其分銷模式以減輕關稅負擔。例如，這些模式包括建立區域分銷中心，以及與當地委託製造合作，在關稅優惠地區進行最終組裝。

此外，日益嚴峻的關稅環境正在加速非價格屬性（例如臨床證據、軟體服務和綜合培訓項目）的競爭差異化。隨著成本壓力波及整個價值鏈，那些能夠提供強大的遠端支援、可預測的維護計劃以及清晰的雲端和人工智慧服務升級路徑的公司，更有可能在價格波動的情況下保持客戶忠誠度。最後，包括供應鏈安全和區域產業政策在內的公共採購政策，正日益影響供應商的選擇，凸顯了採購和營運規劃透明度和韌性的必要性。

將產品類型、可攜性、臨床應用、最終用戶、技術堆疊和價格分佈因素納入策略決策流程，進行全面的市場區隔分析。

攜帶式診斷成像市場的最佳理解方式是透過層級細分，這種細分方式揭示了臨床需求、產品創新和商業性機會的交匯點。產品類型差異涵蓋了電腦斷層掃描 (CT) 的各種類型、分子成像、磁振造影 (MRI) 配置、超音波格式和 X 光解決方案。在此框架下，CT 分為錐狀射束和螺旋兩種配置，每種配置都針對不同的操作限制和空間權衡。分子影像分為正子斷層掃描 (PET) 和單光子發射電腦斷層掃描 (SPECT)，每種類型都有不同的示蹤劑輸送方法和臨床應用場景。磁振造影技術根據磁場強度和設計用途進一步細分，包括用於傳統成像的高場系統、優先考慮性能和部署靈活性的中場系統以及優先考慮便攜性的超低場創新技術。

超音波在便攜性方面呈現出多樣性，從傳統的2D儀器到適用於血管和心臟病學應用的3D和多普勒平台，應有盡有。手持式設備包括專用設備和可連接智慧型手機的型號，而無線配置則包括支援藍牙和Wi-Fi的型號，每種配置在連接性、安全性和整合性方面都有不同的要求。 X光設備也同樣呈現兩極化的趨勢，電腦放射成像和全數位放射線方法在影像處理工作流程和現場儲存要求方面存在差異。便攜性進一步將市場細分為手持式、筆記型電腦式和推車式解決方案。手持式設備分為專用硬體和基於智慧型手機的系統，而筆記型電腦式系統則可以採用標準尺寸或平板電腦的形式。推車式平台包括交流電源供電和電池供電兩種版本，每種版本在行動性和部署場景方面都有相應的限制。

應用細分揭示了可攜式診斷成像技術能夠發揮最大價值的臨床場景。緊急應用場景涵蓋加護治療和創傷工作流程，在這些場景中，快速診斷至關重要；而居家醫療則支援慢性病監測和老年護理。軍事部署必須應對戰區和野戰醫院的限制，而即時診斷應用則涵蓋腹部、心臟、肌肉骨骼、產科和血管等領域。獸醫應用分為大型動物和小型動物兩種模式，每種模式對設備的尺寸和耐用性要求各不相同。最終用戶細分包括診所、診斷中心、居家照護機構、醫院和門診中心。在這些類別中，所有權模式和機構類型（政府診所與私人診所、影像中心與實驗室、私人居家照護機構與公立家庭護理機構、綜合醫院與專科醫院、門診手術中心與門診復健中心）會影響採購週期和支持預期。

技術和價格分佈細分也發揮著重要作用。類比/數位的區分沿著工作流程現代化的方向將市場細分，基於膠片的類比方法逐漸被雲端和本地部署的數位基礎設施所取代，從而改變了影像存取和存檔策略。價格分佈——從經濟實惠的低階設備，到中階入門級和標準型號，再到高階和超高階產品——驅動著不同的價值提案。高階解決方案強調先進的成像功能和全面的服務契約，而低階設備則優先考慮價格實惠和基本的診斷功能。總而言之，這些細分觀點為供應商和買家提供了詳細的路線圖，幫助他們評估產品開發、臨床檢驗和商業性投資的重點方向，以滿足客戶的細微需求。

影響攜帶式診斷影像設備普及的區域採用模式和基礎設施（美洲、歐洲、中東和非洲、亞太地區）

區域趨勢對攜帶式診斷成像技術的應用模式、監管要求和商業策略起著決定性作用。在美洲，人們特別重視與現有醫院網路的整合，急診和門診環境中照護現場的快速普及，以及獎勵能夠顯著提高診療效率和臨床療效的醫保報銷機制。該地區的採購週期往往優先考慮能夠與電子健康記錄 (EHR) 和企業級影像平台無縫整合的設備，而服務網路和應對力在供應商選擇中起著關鍵作用。

歐洲、中東和非洲地區（EMEA）呈現多元化的格局，法規結構、報銷獎勵和融資環境差異顯著。在歐洲部分地區，集中採購和嚴格的臨床管治更傾向於選擇擁有可靠證據包和良好互通性記錄的解決方案。同時，中東市場通常優先考慮快速部署能力和本地支持，而撒哈拉以南非洲地區則特別注重耐用性、能源效率和簡化的維護流程。對於能夠提供適應性強的服務模式和耐用設計，以應對全部區域基礎設施多樣性的供應商而言，存在著巨大的機會。

亞太地區正經歷著由都市化、基層醫療能力提升以及醫療基礎設施的大量投資所驅動的強勁需求。該地區多個國家正在大力推動遠端醫療和居家醫療舉措，這些計劃依賴攜帶式影像設備進行遠距離診斷和慢性病管理。此外，不斷壯大的國內製造業基礎和日益完善的監管體係也在影響採購決策，買家越來越傾向於選擇擴充性、經濟高效且能在不同地區得到支持的設備。這些區域性特徵凸顯了根據當地臨床實務、報銷環境和基礎設施實際情況客製化產品功能、服務內容和商業性策略的重要性。

競爭格局趨勢：傳統製造實力、硬體專用創新與雲端/人工智慧夥伴關係的整合決定市場領導地位

攜帶式診斷影像設備的競爭格局呈現出多元化的特點，既有成熟的原始設備製造商 (OEM)，也有專注於特定領域的創新企業，以及利用軟體和人工智慧來提升診斷價值的靈活Start-Ups。現有企業通常憑藉產品系列、全球服務網路以及完善的監管管道（便於醫療系統進行大規模採購）展開競爭。為了維護機構買家的信任，這些現有企業通常會在上市後監測、臨床研究和全面的培訓計畫方面投入大量資金。

同時，專注於特定領域的專業公司和新參與企業正透過創新推動市場轉型，例如手持式超音波設備、低場磁振造影系統和緊湊型CT設計。它們的優勢在於快速的產品改進、針對特定應用情境的臨床檢驗，以及以軟體訂閱和管理服務為核心的經營模式。硬體開發商與軟體/雲端服務供應商之間的合作日益普遍，使設備能夠提供先進的影像處理、決策支援和遠端會診功能。這種合作模式透過消除影像解讀瓶頸和實現遠端專家協助，降低了臨床應用門檻。

隨著企業尋求將硬體技術與先進的軟體功能和本地分銷經驗相結合，併購、策略聯盟和授權授權已成為反覆出現的主題。對於優先考慮運作和本地維護的分散式醫療環境中的買家而言，供應鏈整合和可維護性仍然是重要的競爭優勢。影像重建演算法、低功耗硬體設計和人工智慧診斷支援工具的智慧財產權也是關鍵的競爭優勢所在，能夠保護這些資產並將其商業化的公司將更有利於獲取長期價值。整體而言，競爭格局往往更有利於那些能夠平衡產品可靠性、軟體驅動的臨床價值和強大的支援基礎設施的公司。

為確保攜帶式診斷影像設備的臨床應用、穩定供應和持續收入來源，設備製造商和醫療保健領導者可採取切實可行的策略重點。

產業領導者應優先考慮整合硬體可靠性、軟體臨床效用和強大的售後支援等綜合價值提案。積極投資於臨床證據產生和獨立檢驗研究將加速醫院採購委員會和認證機構對產品的採納。同時，允許軟體和連接升級的模組化產品架構可延長設備生命週期，並透過託管服務和訂閱模式創造持續收入。

在營運層面，應考慮供應鏈多元化，並考慮區域性最終組裝和委託製造，以降低關稅和物流風險。建立遠距離診斷、預測性維護和備件預測機制，可以減少停機時間，增強客戶信任，尤其是在分散的醫療環境中。商業策略應強調與遠端醫療平台、電子病歷供應商和區域服務機構的合作，以確保無縫整合並降低最終用戶的使用障礙。定價和報銷策略應與已證實的臨床和營運效益一致。試驗基於價值的合約模式有助於充分利用照護現場的效率提升。

最後，對培訓計畫、直覺的使用者介面和臨床醫生決策支援的投資將擴大使用者群體，並減少對專業操作人員的依賴。透過結合臨床檢驗、軟體靈活性、供應鏈韌性和卓越的服務，業界領導者可以將當前的衝擊轉化為永續的競爭優勢，並推動其在醫療保健領域內外廣泛應用。

結合關鍵相關人員訪談、技術文件審查和三角驗證檢驗的穩健混合調查方法，確保了研究結果的可操作性和檢驗。

支持這些發現的研究採用了混合方法，結合一手和二手研究，以確保分析的嚴謹性。一手研究包括對急診醫學、放射學、居家醫療和軍事醫療服務領域的臨床終端用戶、採購負責人和技術專家進行結構化訪談，並輔以與醫療設備製造商的產品經理和供應鏈主管的討論。這些討論重點關注各種便攜格式和臨床應用的實際性能、可維護性問題以及推廣應用障礙。

二次研究包括對同行評審的臨床研究、監管申報文件、產品技術規範以及記錄設備性能特徵、安全性概況和互通性能力的行業白皮書進行系統性回顧。在有權威監管標準和指南的情況下，參考這些標準和指南來理解合規要求並評估臨床實施所需的證據。物流和貿易出版物中的數據用於供應鏈模式和關稅相關影響分析，而技術趨勢報告則有助於了解小型化、互聯互通和基於人工智慧的圖像分析的最新進展。

分析方法包括從細分角度進行比較特徵映射、情境分析以評估供應鍊和關稅方面的突發情況，以及將關鍵發現與已記錄的產品績效進行交叉檢驗。此調查方法的局限性包括不同器械類別的已發表臨床證據存在差異，以及採購和報銷政策存在區域差異。為彌補這些局限性，我們進行了多項獨立的相關人員檢驗，並進行了敏感性檢驗，以確保結論的穩健性。最終形成的框架將經驗觀察與策略解讀相結合，為製造商、供應商和投資者提供決策支援。

結論：整合技術進步、臨床證據和營運韌性是攜帶式診斷影像持續成功的決定因素

攜帶式診斷影像設備正處於轉折點，技術進步、醫療服務模式的轉變以及商業性創新正在融合，從而將診斷範​​圍擴展到傳統環境之外。擁有可靠硬體、靈活的軟體生態系統、強大的售後支援和明確的臨床證據的設備最能滿足日益成長的現場即時診斷需求。對於市場參與企業而言，至關重要的是平衡創新速度和卓越營運，新產品的推出必須伴隨相應的服務模式和整合方案，以降低用戶採用門檻。

監管、關稅和供應鏈方面的壓力要求企業具備策略遠見，包括加強籌資策略、投資本地支援體係以及與買家就生命週期成本進行透明對話。臨床領導者和採購團隊應優先考慮那些具備互通性、安全性和對臨床工作流程有顯著影響的設備。最終，最成功的解決方案將是那些能夠在速度和便利性顯著改善患者預後和系統效率的環境中，提供可靠、易用的診斷影像方案。

透過將產品開發與已證實的臨床需求相結合，並建立穩健的商業和營運基礎設施，相關人員可以加速攜帶式診斷影像技術的普及應用，並將其永續地整合到多樣化的診療路徑中。這一領域的蓬勃發展為那些願意投資於循證實踐、服務性和平台主導的價值創造的企業提供了極具吸引力的機會。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將人工智慧演算法整合到攜帶式診斷成像設備中，用於即時分析
  • 具備遠端醫療連接功能的攜帶式超音波診斷設備的興起（用於遠端醫療和診斷）
  • 開發一種無線、電池供電、可攜式X 光系統，用於野戰醫院的現場放射檢查。
  • 推出用於急診和照護現場診斷的小型化CT掃描儀
  • 擴展雲端基礎的影像儲存和協作平台，以實現攜帶式影像工作流程
  • 監管改革旨在加速創新攜帶式診斷影像設備的核准流程

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章攜帶式診斷影像設備市場（按產品類型分類）

  • CT
    • 錐狀射束CT
    • 螺旋CT
  • 分子影像
    • PET
    • SPECT
  • MRI
    • 高磁場
    • 中等磁場
    • 超低磁場
  • 超音波
    • 2D
    • 3D
    • 多普勒
    • 手持式
      • 專用設備
      • 基於智慧型手機
    • 無線的
      • 藍牙功能
      • 具備 Wi-Fi 功能
  • X光
    • 電腦放射成像
    • 數位放射線

第9章攜帶式診斷影像設備市場（按便攜性類型分類）

  • 手持式
    • 專用設備
    • 基於智慧型手機
  • 筆記型電腦底座
    • 標準整合
    • 平板電腦整合
  • 手推車底座
    • 交流電源
    • 電池供電

第10章攜帶式診斷影像設備市場（按應用分類）

  • 緊急狀況
    • 加護治療
    • 創傷
  • 居家醫療
    • 慢性病監測
    • 老年護理
  • 軍隊
    • 戰鬥區
    • 野戰醫院
  • 照護現場
    • 腹部
    • 心臟病學
    • 肌肉骨骼系統
    • 產科
    • 血管
  • 獸醫學
    • 大型動物
    • 小動物

第11章攜帶式診斷影像設備市場（以最終用戶分類）

  • 診所
    • 政府
    • 私人的
  • 診斷中心
    • 影像中心
    • 考場
  • 居家醫療保健服務提供者
    • 私人的
    • 公共
  • 醫院
    • 一般的
    • 專科醫院
  • 門診治療中心
    • 門診手術
    • 復原

第12章攜帶式診斷影像設備市場（依技術分類）

  • 模擬
    • 薄膜基
  • 數位的
    • 雲端
    • 本地部署

第13章攜帶式診斷影像設備市場（依價格分佈）

  • 高階
    • 優質的
    • 超高階
  • 低階
    • 經濟
  • 中檔
    • 入門級
    • 標準

第14章攜帶式診斷影像設備市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章攜帶式診斷影像設備市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國攜帶式診斷影像設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • GE Healthcare
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • Fujifilm Holdings Corporation
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Samsung Medison Co., Ltd.
    • Hitachi, Ltd.
    • Esaote SpA
    • Shimadzu Corporation
Product Code: MRR-2A0283E25686

The Portable Diagnostic Imaging Market is projected to grow by USD 47.69 billion at a CAGR of 8.08% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 25.59 billion
Estimated Year [2025] USD 27.71 billion
Forecast Year [2032] USD 47.69 billion
CAGR (%) 8.08%

An authoritative introduction to the rapid decentralization of diagnostic imaging driven by miniaturization, connectivity, and clinical workflow transformation

Portable diagnostic imaging has evolved from specialist equipment tethered to hospital imaging suites into a diverse ecosystem of devices that push diagnostic capacity closer to the patient. This transition is driven by technological miniaturization, advances in digital signal processing, and the maturation of wireless connectivity, which together enable devices to operate reliably in clinical, field, and domiciliary settings. As a result, care pathways are becoming more decentralized, with diagnostics delivered at the point of need rather than being concentrated in central facilities.

The convergence of imaging modalities with cloud computing and edge analytics is reshaping clinical workflows and enabling faster triage decisions. Clinicians are using portable CT, MRI variants, ultrasound, molecular imaging, and compact X-ray systems to gather actionable information that previously required patient transport and scheduling delays. From emergency response to home-based chronic disease monitoring, these technologies expand the reach of diagnostic services and support timelier interventions. In parallel, design priorities have shifted toward ergonomic form factors, power efficiency, and simplified user interfaces to minimize training burdens and streamline integration into non-traditional care settings.

Regulatory scrutiny and interoperability standards are increasingly central to product development cycles, and stakeholder expectations for data security and clinical validation are rising. Adoption is therefore mediated not only by device performance, but also by the extent to which vendors can demonstrate robust clinical evidence, reliable lifecycle support, and secure data management. This introduction frames the subsequent analysis by highlighting where the sector is now, the forces shaping near-term competitive advantage, and the operational considerations that will decide which portable imaging solutions achieve broad, sustained adoption.

How miniaturization, software-driven ecosystems, modular interoperability, and supply chain resilience are collectively reshaping portable diagnostic imaging dynamics

The landscape of portable diagnostic imaging is undergoing profound, technology-led shifts that are transforming clinical practice, procurement models, and patient pathways. Technological advances in sensor miniaturization and low-field MRI architectures are enabling devices that are lighter, more energy-efficient, and easier to deploy in constrained environments. Simultaneously, ultrasound systems have progressed from bulky consoles to handheld instruments and smartphone-integrated devices that offer surprisingly sophisticated imaging capabilities, supported by AI-assisted interpretation and automated measurement tools. These innovations lower the barrier to skilled operation and expand the pool of potential users beyond imaging specialists.

Connectivity and software-defined functionality are also creating new value layers. Cloud-enabled platforms and edge computing allow for secure image transfer, remote consultation, and continuous software improvement without hardware replacement. This increases device lifespan and enables subscription-style software monetization. At the same time, modularity and platform approaches are promoting interoperability across modalities, making it simpler for institutions to integrate portable units into existing clinical information systems. Consequently, purchasing decisions are increasingly influenced by a device's ecosystem compatibility and long-term software roadmap rather than by hardware features alone.

Clinical workflow paradigms are shifting as emergency departments, outpatient centers, and home care providers integrate point-of-care imaging to expedite diagnosis. This evolution is supported by reimbursement adjustments in some jurisdictions and by operational incentives to reduce patient throughput times. Finally, supply chain resilience and geographic diversification of component sourcing have become strategic priorities following recent global disruptions, prompting many manufacturers to rethink sourcing strategies and to increase localization of critical components. Together, these transformative shifts are redefining competitive advantage in portable diagnostic imaging and setting the agenda for product roadmaps, commercial models, and regulatory engagement.

Assessing how evolving United States tariff measures through 2025 have reshaped supply chain strategy, procurement trade-offs, and commercial differentiation in imaging

The imposition and evolution of tariffs by the United States through 2025 have had tangible implications for manufacturers, distributors, and healthcare buyers within the portable diagnostic imaging supply chain. Tariffs affecting key components, raw materials, and assembled devices influence cost structures, prompting firms to reassess sourcing strategies and to evaluate the financial viability of regional manufacturing and aftermarket support hubs. In many cases, companies have responded by diversifying supplier bases, increasing inventory buffers, or accelerating localization of assembly and testing processes to mitigate exposure to punitive duties and transit delays.

These shifts are not limited to cost considerations. Tariffs interact with regulatory compliance and logistics complexity to shape go-to-market timing and pricing transparency. Providers that rely on cross-border procurement may encounter longer lead times and more complex warranty administration. Consequently, procurement teams and clinical leaders must weigh the trade-offs between short-term acquisition cost savings and longer-term serviceability, spare-part availability, and lifecycle total cost of ownership. In parallel, firms are revisiting distribution models to reduce tariff drag, for example by establishing regional distribution nodes or by partnering with local contract manufacturers to perform final assembly in tariff-friendly jurisdictions.

Moreover, the tariff environment has intensified competitive differentiation around non-price attributes such as clinical evidence, software services, and integrated training programs. As cost pressures ripple through the value chain, companies that offer robust remote support, predictable maintenance schedules, and clear upgrade paths for cloud and AI-enabled services tend to retain customer trust despite price volatility. Finally, public procurement policies that factor in supply chain security and regional industrial policy are increasingly influencing vendor selection, underscoring the need for transparency and resilience in sourcing and operational planning.

Comprehensive segmentation insights connecting product types, portability formats, clinical applications, end users, technology stacks, and price tiers to strategic decision pathways

The portable diagnostic imaging market is best understood through layered segmentation that reveals where clinical demand, product innovation, and commercial opportunity intersect. Product-type differentiation spans computed tomography variants, molecular imaging, magnetic resonance configurations, ultrasound formats, and X-ray solutions. Within this framework, CT diverges into cone beam and helical architectures, each addressing different procedural and spatial trade-offs. Molecular imaging splits into positron emission tomography and single photon systems, which have distinct tracer logistics and clinical use cases. Magnetic resonance technology is further stratified by field strength and design intent, encompassing high-field systems for conventional imaging, mid-field systems that balance performance and deployment flexibility, and ultra-low-field innovations that prioritize portability.

Ultrasound exemplifies breadth within portability, ranging from traditional two-dimensional devices to three-dimensional and Doppler-capable platforms suited for vascular and cardiology applications. The handheld segment introduces both dedicated devices and smartphone-integrated options, while wireless configurations include Bluetooth-enabled and Wi-Fi-enabled models, each with different implications for connectivity, security, and integration. X-ray follows a similar bifurcation between computed radiography and fully digital radiography approaches, emphasizing differences in image processing workflows and onsite storage requirements. Portability type further segments the market into handheld, laptop-based, and trolley-based solutions; handheld devices differentiate between dedicated hardware and smartphone-based systems, laptop-based systems may be integrated in standard or tablet forms, and trolley-based platforms present AC-operated or battery-operated variants, with corresponding implications for mobility and deployment scenarios.

Application-driven segmentation highlights the clinical contexts where portable imaging delivers the most value. Emergency use cases split into critical care and trauma workflows where rapid diagnostics are essential, while home care supports chronic disease monitoring and elderly care. Military deployments must accommodate combat zone and field hospital constraints, and point-of-care applications cover abdominal, cardiology, musculoskeletal, obstetrics, and vascular indications. Veterinary uses bifurcate into large animal and small animal modalities, each with distinct form factor and durability requirements. End-user segmentation spans clinics, diagnostic centers, home care providers, hospitals, and outpatient centers; within these categories, ownership models and institutional types-government versus private clinics, imaging centers versus laboratories, private versus public home care providers, general versus specialty hospitals, and ambulatory surgical versus rehabilitation outpatient centers-shape procurement cycles and support expectations.

Technology and price-range segmentations also play critical roles. Analog versus digital divides the market along workflow modernization lines, with film-based analog approaches giving way to cloud-enabled and on-premise digital infrastructures that alter image access and archival strategies. Price tiers-from economy low-end devices to mid-range entry and standard models and up to premium and ultra-premium high-end offerings-drive different value propositions, where high-end solutions emphasize advanced imaging capability and comprehensive service contracts, while low-end devices prioritize affordability and basic diagnostic utility. Together, these segmentation lenses provide a detailed map for vendors and buyers to assess where to focus product development, clinical validation, and commercial investment to meet nuanced customer needs.

Regional adoption patterns and infrastructure realities across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine where portable imaging gains traction

Regional dynamics play a decisive role in adoption patterns, regulatory expectations, and commercial strategies for portable diagnostic imaging. In the Americas, there is a pronounced emphasis on integration with established hospital networks, rapid adoption of point-of-care ultrasound in emergency and ambulatory settings, and a reimbursement landscape that rewards demonstrable improvements in throughput and clinical outcomes. Procurement cycles in this region often prioritize devices that can integrate seamlessly with electronic health records and enterprise imaging platforms, and vendor selection is heavily influenced by service networks and responsiveness.

Europe, Middle East & Africa presents a heterogeneous landscape in which regulatory frameworks, reimbursement incentives, and capital availability vary widely. In parts of Europe, centralized procurement and strong clinical governance favor solutions with robust evidence packages and interoperability credentials. Meanwhile, Middle Eastern markets often prioritize rapid deployment capabilities and localized support, and sub-Saharan African contexts place a premium on durability, energy efficiency, and straightforward maintenance protocols. Across this combined region, opportunities exist for vendors that can offer adaptable service models and durable designs that address infrastructure variability.

Asia-Pacific exhibits dynamic demand driven by urbanization, expanding primary care capacity, and significant investments in healthcare infrastructure. Several countries in the region are advancing telemedicine and home healthcare initiatives that rely on portable imaging for remote diagnostics and chronic care management. Additionally, a growing domestic manufacturing base and evolving regulatory infrastructures influence procurement decisions, with buyers seeking scalable, cost-effective devices that can be supported across diverse geographies. These regional profiles underscore the importance of tailoring product feature sets, service offerings, and commercial approaches to local clinical practices, reimbursement environments, and infrastructure realities.

Competitive landscape dynamics where legacy manufacturing strength, focused hardware innovation, and cloud and AI partnerships converge to determine market leadership

The competitive landscape in portable diagnostic imaging is characterized by a mix of established original equipment manufacturers, specialized niche innovators, and agile startups leveraging software and AI to add diagnostic value. Established firms often compete on breadth of product portfolios, global service networks, and established regulatory pathways that facilitate large-scale procurement by health systems. These incumbents typically invest heavily in post-market surveillance, clinical studies, and comprehensive training programs to maintain trust among institutional buyers.

Concurrently, specialized firms and newer entrants are driving disruption through focused innovations in handheld ultrasound, low-field magnetic resonance systems, and compact CT designs. Their strengths lie in rapid iteration, targeted clinical validation in specific use cases, and business models oriented around software subscriptions and managed services. Partnerships between hardware developers and software or cloud providers are increasingly common, enabling devices to offer enhanced image processing, decision support, and teleconsultation capabilities. This collaboration model lowers barriers for clinical adoption by addressing interpretation bottlenecks and by enabling remote expert support.

Mergers, strategic alliances, and licensing agreements are recurrent themes, as companies seek to combine hardware competencies with advanced software capabilities and regional distribution expertise. Supply chain integration and serviceability remain competitive differentiators, particularly for buyers in decentralized care settings who prioritize uptime and local maintenance. Intellectual property in imaging reconstruction algorithms, low-power hardware designs, and AI-enabled diagnostic aids is also a critical axis of competitive advantage, with firms that can protect and commercialize these assets better positioned to capture long-term value. Overall, the company landscape rewards those who can balance product reliability with software-enabled clinical value and resilient support infrastructure.

Actionable strategic priorities for device makers and healthcare leaders to secure clinical adoption, supply resilience, and recurring revenue streams in portable imaging

Industry leaders should prioritize an integrated value proposition that pairs hardware reliability with software-enabled clinical utility and resilient post-sale support. Investing proactively in clinical evidence generation and independent validation studies will accelerate acceptance among hospital procurement committees and credentialing bodies. At the same time, modular product architectures that allow upgrades to software and connectivity features can extend device lifecycles and create recurring revenue through managed services and subscription models.

Operationally, companies should diversify supply chains and consider regional final assembly or contract manufacturing to mitigate tariff and logistics exposure. Building capacity for remote diagnostics, predictive maintenance, and spare-part forecasting will reduce downtime and strengthen customer trust, especially in decentralized care settings. Commercial strategies should emphasize partnerships with telehealth platforms, electronic health record vendors, and local service organizations to ensure seamless integration and to lower adoption friction for end users. Pricing and reimbursement strategies must be aligned with demonstrated clinical and operational benefits; value-based contracting pilots can help capture part of the efficiency gains delivered by point-of-care imaging.

Finally, investing in training programs, intuitive user interfaces, and clinician-facing decision support will broaden the addressable user base and reduce reliance on specialist operators. By combining clinical validation, software flexibility, supply chain resilience, and service excellence, industry leaders can turn current disruptions into durable competitive advantages and drive broader adoption across both institutional and non-institutional care settings.

A robust mixed-methods research approach combining primary stakeholder interviews, technical document review, and triangulated analysis to ensure actionable and validated insights

The research underpinning these insights employed a mixed-methods approach designed to triangulate primary and secondary evidence and to ensure analytical rigor. Primary research included structured interviews with clinical end users, procurement officers, and technical specialists across emergency medicine, radiology, home care, and military medical services, complemented by consultations with product managers and supply chain leaders in device manufacturing. These conversations focused on real-world performance, serviceability concerns, and adoption barriers across a range of portability formats and clinical applications.

Secondary research involved systematic review of peer-reviewed clinical studies, regulatory filings, product technical specifications, and industry whitepapers that document device performance characteristics, safety profiles, and interoperability features. Where available, authoritative standards and guidance from regulatory agencies were consulted to contextualize compliance requirements and to assess evidence expectations for clinical deployment. Data from logistics and trade publications informed analysis of supply chain patterns and tariff-related impacts, while technology trend reports helped frame developments in miniaturization, connectivity, and AI-enabled image analysis.

Analytical techniques included comparative feature mapping across segmentation lenses, scenario analysis to evaluate supply chain and tariff contingencies, and cross-validation of primary insights against documented product performance. Limitations of the methodology include variability in published clinical evidence across device classes and regional heterogeneity in procurement and reimbursement policies. To mitigate these limitations, findings were validated with multiple independent stakeholders and subjected to sensitivity checks to ensure robustness of conclusions. The resulting framework combines empirical observation with strategic interpretation to support decision-making for manufacturers, providers, and investors.

Concluding synthesis that aligns technology progress, clinical evidence, and operational resilience as the determinants of enduring success in portable imaging

Portable diagnostic imaging is at an inflection point where technological progress, changing care delivery models, and commercial innovation converge to expand diagnostic reach beyond traditional settings. Devices that marry dependable hardware with flexible software ecosystems, strong post-sale support, and clear clinical evidence will be best placed to capture the growing demand for point-of-need diagnostics. Market participants must therefore balance innovation velocity with operational excellence, ensuring that new product introductions are accompanied by service models and integration pathways that reduce adoption friction.

Regulatory, tariff, and supply chain pressures require strategic foresight, including reinforcement of sourcing strategies, investment in regional support capabilities, and transparent engagement with buyers about lifecycle costs. Clinical leaders and procurement teams should prioritize devices that demonstrate interoperability, security, and measurable impact on clinical workflows. Ultimately, the most successful solutions will be those that deliver reliable, user-friendly imaging in contexts where speed and access materially improve patient outcomes and system efficiency.

By aligning product development with validated clinical needs and by building resilient commercial and operational infrastructures, stakeholders can accelerate adoption and sustainably embed portable diagnostic imaging into diverse care pathways. The sector's momentum offers a compelling opportunity for those willing to invest in evidence, serviceability, and platform-driven value creation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence algorithms for real-time analysis in portable diagnostic imaging devices
  • 5.2. Rise of handheld ultrasound devices with telemedicine connectivity for remote care and diagnostics
  • 5.3. Development of wireless battery-operated portable X-ray systems for on-site imaging in field hospitals
  • 5.4. Adoption of miniaturized computed tomography scanners for emergency and point-of-care diagnostics
  • 5.5. Expansion of cloud-based image storage and collaboration platforms for portable imaging workflows
  • 5.6. Regulatory updates accelerating approval pathways for innovative portable diagnostic imaging equipment

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Portable Diagnostic Imaging Market, by Product Type

  • 8.1. CT
    • 8.1.1. Cone Beam CT
    • 8.1.2. Helical CT
  • 8.2. Molecular Imaging
    • 8.2.1. PET
    • 8.2.2. SPECT
  • 8.3. MRI
    • 8.3.1. High Field
    • 8.3.2. Mid Field
    • 8.3.3. Ultra Low Field
  • 8.4. Ultrasound
    • 8.4.1. 2D
    • 8.4.2. 3D
    • 8.4.3. Doppler
    • 8.4.4. Handheld
      • 8.4.4.1. Dedicated Device
      • 8.4.4.2. Smartphone Based
    • 8.4.5. Wireless
      • 8.4.5.1. Bluetooth Enabled
      • 8.4.5.2. Wi-Fi Enabled
  • 8.5. X-Ray
    • 8.5.1. Computed Radiography
    • 8.5.2. Digital Radiography

9. Portable Diagnostic Imaging Market, by Portability Type

  • 9.1. Handheld
    • 9.1.1. Dedicated Device
    • 9.1.2. Smartphone Based
  • 9.2. Laptop Based
    • 9.2.1. Standard Integration
    • 9.2.2. Tablet Integration
  • 9.3. Trolley Based
    • 9.3.1. AC Operated
    • 9.3.2. Battery Operated

10. Portable Diagnostic Imaging Market, by Application

  • 10.1. Emergency
    • 10.1.1. Critical Care
    • 10.1.2. Trauma
  • 10.2. Home Care
    • 10.2.1. Chronic Disease Monitoring
    • 10.2.2. Elderly Care
  • 10.3. Military
    • 10.3.1. Combat Zone
    • 10.3.2. Field Hospital
  • 10.4. Point Of Care
    • 10.4.1. Abdominal
    • 10.4.2. Cardiology
    • 10.4.3. Musculoskeletal
    • 10.4.4. Obstetrics
    • 10.4.5. Vascular
  • 10.5. Veterinary
    • 10.5.1. Large Animal
    • 10.5.2. Small Animal

11. Portable Diagnostic Imaging Market, by End User

  • 11.1. Clinics
    • 11.1.1. Government
    • 11.1.2. Private
  • 11.2. Diagnostic Centers
    • 11.2.1. Imaging Centers
    • 11.2.2. Laboratories
  • 11.3. Home Care Providers
    • 11.3.1. Private
    • 11.3.2. Public
  • 11.4. Hospitals
    • 11.4.1. General
    • 11.4.2. Specialty
  • 11.5. Outpatient Centers
    • 11.5.1. Ambulatory Surgical
    • 11.5.2. Rehabilitation

12. Portable Diagnostic Imaging Market, by Technology

  • 12.1. Analog
    • 12.1.1. Film Based
  • 12.2. Digital
    • 12.2.1. Cloud Enabled
    • 12.2.2. On Premise

13. Portable Diagnostic Imaging Market, by Price Range

  • 13.1. High End
    • 13.1.1. Premium
    • 13.1.2. Ultra Premium
  • 13.2. Low End
    • 13.2.1. Economy
  • 13.3. Mid Range
    • 13.3.1. Entry Level
    • 13.3.2. Standard

14. Portable Diagnostic Imaging Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Portable Diagnostic Imaging Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Portable Diagnostic Imaging Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. GE Healthcare
    • 17.3.2. Siemens Healthineers AG
    • 17.3.3. Koninklijke Philips N.V.
    • 17.3.4. Canon Medical Systems Corporation
    • 17.3.5. Fujifilm Holdings Corporation
    • 17.3.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 17.3.7. Samsung Medison Co., Ltd.
    • 17.3.8. Hitachi, Ltd.
    • 17.3.9. Esaote S.p.A.
    • 17.3.10. Shimadzu Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABILITY TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABILITY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRICE RANGE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRICE RANGE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. PORTABLE DIAGNOSTIC IMAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. PORTABLE DIAGNOSTIC IMAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PORTABLE DIAGNOSTIC IMAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HELICAL CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HELICAL CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HELICAL CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HELICAL CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HELICAL CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HELICAL CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SPECT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SPECT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SPECT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SPECT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SPECT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SPECT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH FIELD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH FIELD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH FIELD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH FIELD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH FIELD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH FIELD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MID FIELD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MID FIELD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MID FIELD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MID FIELD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MID FIELD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MID FIELD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA LOW FIELD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA LOW FIELD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA LOW FIELD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA LOW FIELD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA LOW FIELD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA LOW FIELD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 2D, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 2D, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 2D, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 2D, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 2D, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 2D, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 3D, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 3D, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 3D, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 3D, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 3D, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 3D, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BLUETOOTH ENABLED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BLUETOOTH ENABLED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BLUETOOTH ENABLED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BLUETOOTH ENABLED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BLUETOOTH ENABLED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BLUETOOTH ENABLED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WI-FI ENABLED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WI-FI ENABLED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WI-FI ENABLED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WI-FI ENABLED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WI-FI ENABLED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WI-FI ENABLED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABILITY TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABILITY TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY STANDARD INTEGRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY STANDARD INTEGRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY STANDARD INTEGRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY STANDARD INTEGRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY STANDARD INTEGRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY STANDARD INTEGRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TABLET INTEGRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TABLET INTEGRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TABLET INTEGRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TABLET INTEGRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TABLET INTEGRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TABLET INTEGRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY AC OPERATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY AC OPERATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY AC OPERATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY AC OPERATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY AC OPERATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY AC OPERATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BATTERY OPERATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BATTERY OPERATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BATTERY OPERATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BATTERY OPERATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BATTERY OPERATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BATTERY OPERATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CRITICAL CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CRITICAL CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CRITICAL CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CRITICAL CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CRITICAL CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CRITICAL CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TRAUMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TRAUMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TRAUMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TRAUMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TRAUMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TRAUMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ELDERLY CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ELDERLY CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ELDERLY CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ELDERLY CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ELDERLY CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ELDERLY CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMBAT ZONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMBAT ZONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMBAT ZONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMBAT ZONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMBAT ZONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMBAT ZONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY FIELD HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY FIELD HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY FIELD HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY FIELD HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY FIELD HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY FIELD HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ABDOMINAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ABDOMINAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ABDOMINAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ABDOMINAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ABDOMINAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ABDOMINAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 304. GLOBA